DISSEQ - Double-blind Exome and Large Gene Panel Sequencing Analyses in the First-Line Diagnosis of 330 Patients with Intellectual Disability (ID): ES Superiority for the Identification of CNV, Variants in New Disease-Causing Genes, and New Candidate Genes, As Well As the Advantage of Possible Prospective Reanalysis